MISSION
This Group aims to challenge, re-define and develop standards of care for loco-regional as well as systemic treatments for lung cancer. This extends to mesothelioma and thymomas. Projects are designed to integrate disciplines such as imaging, translational research, quality of life and quality assurance. The Group is also focused on studying the use of immunotherapy to treat lung cancer.
PRACTICE CHANGING RESEARCH
LATEST PUBLICATIONS
Want to read in detail our scientific findings on specific tumour type?
Search through our comprehensive list of EORTC published articles to date.
